Edwards Lifesciences Corp.

EW NYS
Pharmaceuticals
Irvine, CA
2016 Revenue (US$ Millions)$2,964
Revenue Growth (%)18.85%
2015 Revenue (US$ Millions)$2,494
Net Income (US$ Millions)$570
Common Shares Outstanding (Millions)211.6
Earnings Per Share (US$)$2.61
Price to Earnings Ratio45.45
Total Equity (US$ Millions)$2,619
Return on Equity (%)22.75%
Long Term Debt (US$ Millions)$822
Debt to Equity Ratio (%)0.31%
Market Capitalization (US$ Millions)$19,827
Total Assets (US$ Millions)$4,510
Current Assets (US$ Millions)$2,240
Inventories (US$ Millions)$397
Current Liabilities (US$ Millions)$533
Cost Of Goods Sold (US$ Millions)$797
Asset Turnover0.69
Inventory Turnover2.17